Here are the top stories from the last week:

Industry Updates

Retailers Put AI to Work
In retail pharmacies, AI is now being used to automate tasks like processing prescriptions and analyzing patient data. Read article »

Walmart Intros Digital Services to Help Medicare Advantage Customers
Services include identifying benefits-eligible products and tracking spending in real-time, enhancing the shopping experience for health benefits. Read article »

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice. Read article »

Study Reveals Impact of RSV on the Heart
New research highlights the significant cardiovascular risks associated with RSV, emphasizing the need for vaccination to protect vulnerable populations. Read article »

Express Scripts and CVS Health Sue to Block Arkansas PBM Law
The lawsuits argue that the law, scheduled to take effect in 2026, is unconstitutional under multiple provisions. Read article »

NACDS Praises Texas for Landmark PBM Reform Legislation, SB 1236
This milestone legislation, passed unanimously by the Texas Legislature and championed by Senator Bryan Hughes and Representative Cody Harris, marks a significant moment in the fight for fairness, transparency, and access to pharmacy care. Read article »

CMS Increasing Oversight on States Using Medicaid Funding for Illegal Immigrants
As part of the action, CMS is ramping up financial oversight across the board to identify and stop improper spending. Read article »

RFK Jr. Stops COVID Shot Recommendation for Children, Pregnant Women
The move effectively shortcuts a process set up by the agency’s outside advisers to discuss and make changes to the CDC’s influential vaccination guidance. Read article »

LifeMD & Novo Nordisk Launch $299 Intro Bundle for Self-Pay Wegovy Patients
Bundled offer includes Wegovy at $199 and LifeMD’s Virtual Weight Loss Program for a total first-month cost of $299, $599 per month thereafter. Read article »

Small Pharmacies Stockpile Drugs as Tariff Fears Grow
A new report from KFF Health News details pharmacies stocking their basements full of generic and specialty drugs as a hedge against supply shocks. Read article »

Drug, Technology & Treatment Updates

Fresenius Kabi Releases Epinephrine Injection in New Dosage Strength
This new dosage strength is part of their efforts to provide cost-effective solutions for quality patient care. Read article »

FDA Approves Khindivi, First Oral Solution of Hydrocortisone, for Pediatric Patients
The formulation allows for individualized treatment in children with adrenocortical insufficiency. Read article »

Alcon Announces FDA Approval of TRYPTYR for Dry Eye Disease
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1. Read article »

Eden Intros Rx-only NAD+ Face Cream to Support Skin Resilience & Cellular Wellness
The topical formulation is now accessible in all 50 states following a consultation with a licensed medical provider via Eden’s telehealth platform. Read article »

‍